Merck reported EUR2.15B in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Adidas ADS:GR EUR 3.26B 481M
Adyen ADYEN:NA EUR 3.34B 454.26M
Akzo Nobel AKZA:NA EUR 1.88B 64M
Alcon AG ALC:SW USD 972M 6M
Amadeus IT AMS:SM EUR 310.4M 7.8M
Amarin AMRN:US USD 23.94M 11.87M
Artemis Alpha ATS:LN GBP 507K 125K
AstraZeneca AZN:LN USD 2.12B 214M
Bayer BAYN:GR EUR 4.25B 1.43B
Covestro 1COV:GR EUR 4.06B 275M
Fresenius FRE:GR EUR 7.75B 414M
Fresenius Medical Care FME:GR EUR 3.74B 326M
Galapagos GLPG:NA EUR 2.39M 240K
Givaudan GIVN:VX CHF 2.19B 257M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Hikma Pharmaceutical HIK:LN USD 590M 62M
Infineon Technologie IFX:GR EUR 2.3B 250M
Linde LIN:GR USD 5.28B 345M
Merck MRK:GR EUR 2.15B 38M
Novartis NOVN:VX USD 3.66B 92M
Philips PHIA:NA EUR 2.58B 135M
Roche Holding ROG:VX 9.56B 717M